Brief: Rovi Sees 2026 Operating Revenue To Increase By Up To Low Double-Digit Percentage Vs 2025
06/11/2025 07:18
Nov 6 (Reuters) - Laboratorios Farmaceuticos ROVI SA ROVI.MC: 9-MONTH EBITDA 149.5 MILLION EUROS 9-MONTH NET PROFIT 97.7 MILLION EUROS 9-MONTH OPERATING REVENUE 525.1 MILLION EUROS SEES 2026 OPERATING REVENUE TO INCREASE BY BETWEEN A HIGH SINGLE-DIGIT AND LOW DOUBLE-DIGIT PERCENTAGE VERSUS 2025 Source text Further company coverage: ROVI.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 567 69 66 00;))